Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E30.59 EPS (ttm)5.40 Insider Own0.10% Shs Outstand2.63B Perf Week2.99%
Market Cap429.91B Forward P/E16.01 EPS next Y10.31 Insider Trans-2.06% Shs Float2.61B Perf Month3.01%
Income14.41B PEG3.76 EPS next Q2.34 Inst Own69.90% Short Float0.63% Perf Quarter2.13%
Sales82.58B P/S5.21 EPS this Y-4.20% Inst Trans-0.07% Short Ratio1.97 Perf Half Y14.27%
Book/sh24.04 P/B6.87 EPS next Y8.54% ROA8.90% Target Price185.44 Perf Year7.97%
Cash/sh9.68 P/C17.07 EPS next 5Y8.14% ROE23.40% 52W Range133.65 - 173.65 Perf YTD4.96%
Dividend4.04 P/FCF44.28 EPS past 5Y-0.30% ROI14.60% 52W High-4.88% Beta0.71
Dividend %2.45% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin65.70% 52W Low23.59% ATR2.52
Employees134500 Current Ratio1.20 Sales Q/Q8.30% Oper. Margin20.00% RSI (14)58.79 Volatility1.77% 1.46%
OptionableYes Debt/Eq0.56 EPS Q/Q-56.60% Profit Margin17.80% Rel Volume0.86 Prev Close165.18
ShortableYes LT Debt/Eq0.52 EarningsApr 20 BMO Payout71.20% Avg Volume8.29M Price165.18
Recom1.90 SMA201.20% SMA502.06% SMA2007.75% Volume0 Change0.00%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Apr-23-21 08:45AM  
08:40AM  
08:19AM  
08:12AM  
06:34AM  
06:00AM  
01:38AM  
12:34AM  
12:25AM  
Apr-22-21 08:34PM  
06:59PM  
06:46PM  
05:19PM  
05:08PM  
01:24PM  
12:17PM  
11:50AM  
11:48AM  
11:42AM  
11:16AM  
10:46AM  
10:37AM  
10:19AM  
06:58AM  
Apr-21-21 05:46PM  
04:01PM  
02:59PM  
02:58PM  
02:13PM  
01:07PM  
11:54AM  
11:42AM  
10:35AM  
10:23AM  
10:17AM  
10:11AM  
10:08AM  
10:07AM  
10:04AM  
09:56AM  
09:39AM  
09:30AM  
09:14AM  
08:17AM  
07:30AM  
07:15AM  
07:01AM  
06:42AM  
06:30AM  
06:07AM  
06:01AM  
06:01AM  
Apr-20-21 05:58PM  
05:57PM  
05:40PM  
04:31PM  
04:10PM  
03:37PM  
03:35PM  
03:24PM  
03:15PM  
03:05PM  
02:47PM  
02:15PM  
01:15PM  
12:54PM  
12:24PM  
12:09PM  
12:08PM  
12:02PM  
12:00PM  
11:54AM  
11:26AM  
11:04AM  
11:02AM  
10:48AM  
10:33AM  
10:32AM  
10:31AM  
10:27AM  
10:26AM  
09:46AM  
09:42AM  
09:35AM  
08:37AM  
08:26AM  
08:19AM  
08:12AM  
07:55AM  
07:50AM  
06:57AM  
06:45AM  
06:41AM  
06:37AM  
06:30AM  
06:30AM  
06:30AM  
06:09AM  
04:37AM  
02:38AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM